Stanford University School of Medicine has an Eating Disorders Research Program. Eating disorders are known to affect an individuals quality of life and can cause a number of severe and life-threatening medical issues. It is known that eating disorders have the highest mortality rate of all psychological disorders.
Stanford University School of Medicine Conducting Phentermine Research
Early detection followed by treatment is very important to prevent illness down the road. This team of experts seek to understand and evaluate treatments through state-of-the-art research. They evaluate both therapies and therapeutic out comes as basic science at the level of brain function and imaging.
Stanford is looking for individuals who have any type of binge eating disorders including Bulimia who live near the Stanford University School of Medicine (291 Campus Drive, Stanford, CA 94305) to participate in a new drug trial. For those of you not familiar with Bulimia, it is a potentially life-threatening eating disorder that has cycles of food binge behaviors (excessive eating at one time) along with self-induced vomiting to try to undo the food binge behavior.
Stanford currently has a group of researchers who are actively looking for adults to participate in a drug trial involving a combination of two different drugs. One drug is topiramate and the other is low dose phentermine. You’ll be pleased to know that topiramate and phentermine have been approved by the U.S. Food and Drug Administration (USDA) for the treatment of obesity.
Example of Benge Eating
The goal of this trial is to test whether the combination of Topiramate and Phentermine will decrease the symptoms of both of those two eating disorders. If you know of someone who qualifies for this trial and lives close to Stanford, California, please have them contact the Eating Disorders Research Program (contact information is below).
The trial requires up to 60 men and women between the ages of 18 and 60 whose BMI (body mass index) are 21.0 or greater. The trial will run for 6 months. You will be required to return to Stanford upon request after the trial for a checkup.
The purpose of this trail is to see whether Topiramate (already proven to be effective against the two eating disorders mentioned here) when taken with low dose phentermine will decrease some of the other symptoms of those conditions including fatigue and cognitive dysfunction.
Qsymia – Phentermine / Topiramate
You’ll be pleased to know that anyone participating in the trial will receive up to $100 for completing the trial. For more information about this eating disorder trial please call (650) 723-2242 or email firstname.lastname@example.org.
Various types of binge eating disorders have major impacts on individual physiological and psychological aspects along with the social costs involved. This research is much needed to determine best plans of action for individual health (both physically and psychologically).